Complement component c5 antibodies
US-2025304667-A1 · Oct 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Muchhal Umesh patents
Muchhal Umesh is listed as an inventor on 44 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Muchhal Umesh |
| Total patents | 44 |
| First publication | Aug 27, 2015 |
| Latest publication | Oct 2, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2025304724-A1 · Oct 2, 2025 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-12359002-B2 · Jul 15, 2025 · US
Heterodimeric antibodies that bind cd3 and cd38
US-2025109214-A1 · Apr 3, 2025 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2025109215-A1 · Apr 3, 2025 · US
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
US-12152076-B2 · Nov 26, 2024 · US
Heterodimeric antibodies that bind CD3 and CD38
US-12129309-B2 · Oct 29, 2024 · US
Complement component c5 antibodies
US-2024279317-A1 · Aug 22, 2024 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-11945880-B2 · Apr 2, 2024 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-11859011-B2 · Jan 2, 2024 · US
Recent patents
Latest publications not already listed above.
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2023365717-A1 · Nov 16, 2023 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-11673972-B2 · Jun 13, 2023 · US
Heterodimeric antibodies that bind cd3 and cd38
US-2022403049-A1 · Dec 22, 2022 · US
Bispecific and monospecific antibodies using novel anti-pd-1 sequences
US-2022204624-A1 · Jun 30, 2022 · US
Heterodimeric antibodies that bind CD3 and CD38
US-11352442-B2 · Jun 7, 2022 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2022162343-A1 · May 26, 2022 · US
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
US-11312770-B2 · Apr 26, 2022 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2022041757-A1 · Feb 10, 2022 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-11225528-B2 · Jan 18, 2022 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-11111315-B2 · Sep 7, 2021 · US
Complement component c5 antibodies
US-2021101965-A1 · Apr 8, 2021 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2021102003-A1 · Apr 8, 2021 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-10913803-B2 · Feb 9, 2021 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-10889653-B2 · Jan 12, 2021 · US
Complement component C5 antibodies
US-10752678-B2 · Aug 25, 2020 · US
Heterodimeric antibodies that bind cd3 and cd38
US-2020199251-A1 · Jun 25, 2020 · US
Heterodimeric antibodies that bind CD3 and CD38
US-10526417-B2 · Jan 7, 2020 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2019202938-A1 · Jul 4, 2019 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-10259887-B2 · Apr 16, 2019 · US
Heterodimeric antibodies that bind cd3 and cd38
US-2018305465-A1 · Oct 25, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Xencor Inc | 43 |
| Allergan Inc | 9 |
| Amgen Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 44 |
| C07K2317/565 | 40 |
| C07K2317/24 | 40 |
| C07K2317/31 | 35 |
| C07K16/468 | 35 |